Cardio Diagnostics Holdings, Inc. (CDIO)

NASDAQ: CDIO · Real-Time Price · USD

1.290

+0.240 (22.86%)

At close: Feb 6, 2026, 4:00 PM EST

1.250

-0.040 (-3.10%)

After-hours: Feb 6, 2026, 7:29 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Artificial Intelligence-driven DNA Biomarker Testing Technology	34.89K
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth	104.45%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	34.89K
United States Growth	104.45%